๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Genetic characterization of hypervariable region 1 in patients chronically infected with hepatitis C virus genotype 2

โœ Scribed by Xiaofeng Fan; Adrian M. Di Bisceglie


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
164 KB
Volume
64
Category
Article
ISSN
0146-6615

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

The hypervariable region 1 (HVR1) has been most reliably identified in the genome of HCV genotype 1 isolates and thought to possibly play a role in immune evasion and development of chronic infection. There are few studies, however, of other HCV genotypes to determine if they also have such a hypervariable region present, and it is unclear whether or not there is any genotypeโ€dependent difference in the genetic characteristics of HVR1. We determined the nucleotide sequence of 5โ€ฒ end of E2/NS1 region of the HCV genome spanning HVR1 of multiple genotype 1 and 2 HCV isolates and carried out a detailed genetic analysis. Similarity plots identified two hypervariable regions within the genotype 2 sequences, a larger one corresponding to HVR1 as well as a smaller 27โ€nucleotide region of hypervariability. The synonymous substitutions per synonymous site (ds) was greater than nonsynonymous substitutions per nonsynonymous site (dn) within genotype 1 group whereas dn and ds were similar in the genotype 2 group. Analysis of amino acid sequences revealed several conserved sites across genotype 1 and 2 (amino acid numbers 2,6, 20 and 26) and overall similar hydropathic profiles were found within two genotypes. Still, despite the hypervariability, the HVR1 showed a genotypeโ€specific phylogenetic clustering. Thus, HVR1 appears to be conserved between genotypes in keeping with it having an important survival function. Genotype 2 appears to have a greater rate of nonsynonymous substitutions within HVR1, suggesting a greater positive evolutionary pressure. J. Med. Virol. 64:325โ€“333, 2001. ยฉ 2001 Wileyโ€Liss, Inc.


๐Ÿ“œ SIMILAR VOLUMES


Genetic variability of hepatitis C virus
โœ I. Vuillermoz; E. Khattab; E. Sablon; I. Ottevaere; D. Durantel; C. Vieux; C. Tr ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 202 KB ๐Ÿ‘ 2 views

## Abstract Little is known about hepatitis C virus (HCV) breakthrough during antiviral therapy, although it would help in understanding HCV resistance to current antiviral treatments. To analyse the implication of virological factors and the vigour of humoral immune responses in this phenomenon, w

The prevalence of hepatitis B virus preS
โœ Ho-Suk Mun; Seoung-Ae Lee; Youngmee Jee; Hong Kim; Joo-Hee Park; Byung-Cheol Son ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 175 KB ๐Ÿ‘ 2 views

## Abstract Although Korea is one of the endemic areas for hepatitis B virus infection (HBV), the prevalence of deletions in HBV preS region occurring naturally have not been determined. In the present study, the prevalence of preS deletions was determined in terms of clinical state and HBeAg seros

Virological outcomes in patients infecte
โœ Mariko Kobayashi; Norio Akuta; Fumitaka Suzuki; Yoshiyuki Suzuki; Yasuji Arase; ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 259 KB ๐Ÿ‘ 1 views

## Abstract In a single hospital in Tokyo, the 87 patients infected persistently with hepatitis B virus (HBV) genotype A, the 413 with B, and the 3,389 with C were compared for virological outcome. Hepatitis B surface antigen (HBsAg) was cleared from the serum in 12% (3/26), 2% (2/112), and 3% (23/

Genetic heterogeneity of the NS3 proteas
โœ Sophie Vallet; Stephanie Gouriou; Jean-Baptiste Nousbaum; Marie-Christine Legran ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 242 KB ๐Ÿ‘ 1 views

## Abstract NS3 protease is essential for hepatitis C Virus (HCV) replication, and is one of the most promising targets for specific antiโ€HCV therapy. Its natural polymorphism has not been studied at the quasispecies level. In the present work, the genetic heterogeneity of the NS3 protease gene was